Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test
Abstract
A point-of-care, microfluidic platform detects antibodies against three SARS-CoV-2 antigens from blood in less than an hour.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 25, 2021
- Source ID
- 10.1126/sciadv.abg4901
Entities
People
- Angus M. Hucknall
- Ashutosh Chilkoti
- Bruce A. Sullenger
- Bryan Kraft
- Carl F Pieper
- Cassio M Fontes
- Christopher W Woods
- Daniel Y Joh
- David Kinnamon
- Garrett Kelly
- Gregory D Sempowski
- Ibtehaj A. Naqvi
- Jack G. Anderson
- Jacob T. Heggestad
- Jason Liu
- Lingye Chen
- Loretta G Que
- Lyra B. Olson
- Simone A. Wall
- Smita K Nair
- Solomon Oshabaheebwa
- Thomas Burke
- Thomas H Oguin
- Zachary Quinn
Organizations
- Duke University
- Duke University Hospital
- Ministry of Defence
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Science Foundation
- United States Department of Defense